About
Respiratory Therapies
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Team (17)
Albert Dahan M
Enalare Therapeutics
team_member
Alexander Kraus
Enalare Therapeutics
team_member
David Battleman
Enalare Therapeutics
team_member
Enalare Financial Conflict of Interest Policy
Enalare Therapeutics
team_member
Eugene Vortsman
Enalare Therapeutics
team_member
Frank Diana
CMC & Formulation Development
Enalare Therapeutics
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
218
By Phase
PHASE2: 1PHASE1: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06137638Lead Sponsor
ENA-001 for Post Operative Respiratory Depression (PORD)
PHASE2Not yet recruiting
200 participants
Started: Mar 15, 2026 · Completed: Dec 15, 2026
NCT06967259Lead Sponsor
ENA-001 for Opioid Induced Respiratory Depression
PHASE1Recruiting
18 participants
Started: May 14, 2025 · Completed: Nov 5, 2025
Locations (1)
Headquarters
Princeton, NJ, United States
Map
Loading map...